Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

571 articles

Research Review

Showing 1–3 of 3 articles · Keyword: Photodynamic therapy Clear keyword

International journal of pharmaceutics2026ResearchDrug Delivery

1. Laser-responsive chitosan-coated solid lipid nanoparticles co-encapsulating CaO 2 nanoparticles and IR780 for on-demand and enhanced photodynamic therapy of cancers

Amiri M, Heydari E, Esmaeili M, Zare-Behtash H, Moeini M

The photodynamic therapy (PDT) efficacy is limited by tumor hypoxia and inefficient intracellular accumulation of photosensitizers (PSs). This study reports chitosan-coated solid lipid nanoparticles (SLNs) co-encapsulating the near-infrared photosensitizer IR780 and oxygen-generating CaO 2 nanoparticles (NPs) for…

Read the article

Pharmaceutics2026ReviewDrug Delivery

2. Cell Membrane-Coated Nanoparticles as Biomimetic Drug Delivery Systems: Design, Therapeutic Applications, and Translational Challenges

Jacob S, Varkey Nr, Rao R, Shinu P, Khanam R

Biomimetic cell membrane-coated nanoparticles (CM-NPs) have emerged as a promising class of nanocarriers that integrate the tunable physicochemical properties of engineered nanoparticles with selected biological features of naturally derived cell membranes.

Read the article

Frontiers in oncology2026ReviewDrug Delivery

3. Extracellular vesicles as biomimetic platforms for photo-assisted cancer therapy: evolution from synthetic nanocarriers to engineered therapeutic systems

Beaugé L, Ibarra Le

Photo-assisted therapies have emerged as promising strategies for cancer treatment by combining localized tumor ablation with the induction of systemic antitumor immune responses. Despite encouraging preclinical and clinical advances, their therapeutic efficacy remains limited by the unfavorable pharmacokinetics…

Read the article

Let's engineer the next delivery breakthrough together

We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.

ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.